Signaling pathways
-
F1703 Anti-FcRn (FCGRT & B2M) Antibody (Orilanolimab)Summary: Anti-FcRn (FCGRT & B2M) Antibody (Orilanolimab) -
F1704 Anti-B7-H2/ICOSL/CD275 Antibody (Prezalumab)Summary: Anti-B7-H2/ICOSL/CD275 Antibody (Prezalumab) -
F1705 Anti-Fibronectin Antibody (Radretumab)Summary: Anti-Fibronectin Antibody (Radretumab) -
F1706 Anti-FcRn (FCGRT & B2M) Antibody (Rozanolixizumab)Summary: Anti-FcRn (FCGRT & B2M) Antibody (Rozanolixizumab) -
F1707 Anti-FZD10 Antibody (Tabituximab)Summary: Anti-FZD10 Antibody (Tabituximab) -
F1708 Anti-DPEP3 Antibody (Tamrintamab)Summary: Anti-DPEP3 Antibody (Tamrintamab) -
F1709 Anti-GDF8/Myostatin Antibody (Trevogrumab)Summary: Anti-GDF8/Myostatin Antibody (Trevogrumab) -
F1710 Anti-KLK2/Kallikrein 2 Antibody (JNJ-69086420)Summary: Anti-KLK2/Kallikrein 2 Antibody (JNJ-69086420) -
F1711 Anti-Klotho Beta Antibody (RG7992)Summary: Anti-Klotho Beta Antibody (RG7992) -
F1712 Anti-Lewis Y Antibody (MB 311)Summary: Anti-Lewis Y Antibody (MB 311)